News
A growing trend towards pharmaceutical outpatient treatment spending is driven by accessibility, according to Eric Tichy, ...
In a conversation with Managed Healthcare Executive, Hunter expressed that work requirements are an effective way to manage Medicaid eligibility, but what is proposed will cause more harm to those who ...
Jason R. Smith, Pharm.D., appointed as chief pharmacy officer in February 2025 for the University of Rochester Medical Center ...
Almost half (48%) of HIV patients sometimes feel unheard by their healthcare providers, which highlights a need for increased ...
In this second part of a video series, Managed Healthcare Executive caught up with CareOregon CEO Eric C. Hunter, who voiced concern about the consequences of rising anti-DEI views and potential ...
Proportion and Costs of Hospitalizations for Cirrhosis With AKI and HRS Are Rising Fast, Study Finds
Researchers found that nearly 28% of hospitalized chronic liver disease patients with acute kidney injury had alcohol-related disorders, as did almost 60% with hepatorenal syndrome.
Patients diagnosed with acquired (autoimmune) hemophilia, a serious and rare bleeding disorder, have high rates of hospital ...
Scientists working at the NIH’s BRAIN Initiative have created new viral vectors that one day could lead to gene therapies for ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Developed by Sarepta Therapeutics, Elevidys is a one-time, intravenous treatment that uses adeno-associated virus (AAV) ...
Health plan sponsors are also expected to see a reduction in the net cost per prescription of GLP-1 medications to treat obesity.
Nucula’s new indication is as an add-on therapy for patients with COPD who also have an elevated blood eosinophil count.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results